Integra Lifesciences Holdings (STU:IL3) Institutional Ownership: 57.84% (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:IL3 Integra Lifesciences Holdings Corp STU:IL3
73 GF Score
Price €16.60
GF Value €20.93
Valuation Modestly Undervalued
! 11 Warning Signs
View Full Analysis

What is Integra Lifesciences Holdings Institutional Ownership?

Integra Lifesciences Holdings STU:IL3 -1.19% 73 Institutional Ownership is 57.84% as of Jul. 21, 2026. GuruFocus rates STU:IL3 with a GF Score™ of 73/100 and a GF Value™ of €20.93 (Modestly Undervalued). The stock has 11 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Integra Lifesciences Holdings's institutional ownership is 57.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Integra Lifesciences Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Integra Lifesciences Holdings's Float Percentage Of Total Shares Outstanding is 72.52%.

Integra Lifesciences Holdings Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Integra Lifesciences Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integra Lifesciences Holdings Institutional Ownership Chart

Integra Lifesciences Holdings Historical Data

The historical data trend for Integra Lifesciences Holdings can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 60.20 59.93 59.28 59.45 58.65 58.74 58.62 58.39 57.97 57.84
STU:IL3
73GF Score
Integra Lifesciences Holdings Corp STU:IL3
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integra Lifesciences Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 57.84% mean?
Integra Lifesciences Holdings (STU:IL3) has a Institutional Ownership of 57.84% as of Jul. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Integra Lifesciences Holdings and its competitors.
Is Integra Lifesciences Holdings' Institutional Ownership too high?
Integra Lifesciences Holdings' current Institutional Ownership is 57.84%. Overall, Integra Lifesciences Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integra Lifesciences Holdings' Institutional Ownership compare to ATEC and AHCO?
Integra Lifesciences Holdings' Institutional Ownership of 57.84% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Integra Lifesciences Holdings and its competitors. Integra Lifesciences Holdings's current Institutional Ownership is 57.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integra Lifesciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integra Lifesciences Holdings (STU:IL3) is currently considered Modestly Undervalued. The stock's GF Value™ is €20.93, compared to a current price of €16.60 — trading 20.7% below its estimated fair value. The current Institutional Ownership is 57.84%. Integra Lifesciences Holdings' overall GF Score™ is 73/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Integra Lifesciences Holdings (STU:IL3), the current Institutional Ownership is 57.84% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integra Lifesciences Holdings (STU:IL3) Overvalued in 2026?

Based on GuruFocus' analysis, Integra Lifesciences Holdings stock appears to be undervalued. The current stock price of €16.60 is trading 20.7% below its estimated GF Value™ of €20.93. GuruFocus considers Integra Lifesciences Holdings to be Modestly Undervalued.

Key valuation signals for STU:IL3:

  • Institutional Ownership: 57.84%
  • GF Value™: €20.93 vs. price of €16.60 (20.7% below fair value)
  • GF Score™: 73/100 with 11 warning signs

No single metric tells the full story. See the STU:IL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integra Lifesciences Holdings Business Description

Other Exchanges IART:USA
Address 1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
73GF Score

Get the complete analysis for STU:IL3

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.60
Price
€20.93
GF Value